Walleye Capital LLC Sage Therapeutics, Inc. Transaction History
Walleye Capital LLC
- $54.6 Billion
- Q1 2024
A detailed history of Walleye Capital LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 2,500 shares of SAGE stock, worth $26,549. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,500
Previous 20,200
87.62%
Holding current value
$26,549
Previous $437,000
89.47%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding SAGE
# of Institutions
222Shares Held
52.7MCall Options Held
207KPut Options Held
191K-
Vanguard Group Inc Valley Forge, PA5.75MShares$61.1 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.48MShares$58.2 Million1.65% of portfolio
-
Black Rock Inc. New York, NY4.89MShares$52 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA4.75MShares$50.5 Million0.02% of portfolio
-
State Street Corp Boston, MA4.49MShares$47.7 Million0.0% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $631M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...